Pharmabiz

Merck, Pfizer receive FDA Breakthrough Therapy status for avelumab in metastatic MCC

Merck, Pfizer receive FDA Breakthrough Therapy status for avelumab in metastatic MCC: New York Friday, November 20, 2015, 10:00 Hrs [IST] Merck KGaA, Darmstadt, Germany, and Pfize ...
Pharmabiz

US FDA grants priority review for Alexion's sBLA for Soliris to treat atypical Haemolytic Uremic Syndrome

US FDA grants priority review for Alexion's sBLA for Soliris to treat atypical Haemolytic Uremic Syndrome: Cheshire Connecticut Friday, June 3, 2011, 17:00 Hrs [IST] Alexion Pharm ...
Pharmabiz

Contineum Therapeutics phase 2 PIPE-307 VISTA trial to treat RRMS fails to meet its prespecified primary or secondary efficacy endpoints

Contineum Therapeutics phase 2 PIPE-307 VISTA trial to treat RRMS fails to meet its prespecified primary or secondary efficacy endpoints: San Diego Saturday, November 22, 2025, 18 ...
Pharmabiz

BioNxt Solutions receives Eurasian Patent for sublingual cladribine platform

BioNxt Solutions receives Eurasian Patent for sublingual cladribine platform: Vancouver, BC Saturday, November 22, 2025, 17:00 Hrs [IST] BioNxt Solutions Inc. (BioNxt), a bioscien ...
Pharmabiz

iZafe Group inks distribution agreement with Skand to launch of Dosell on the Icelandic market

Zafe Group inks distribution agreement with Skand to launch of Dosell on the Icelandic market: Stockholm Saturday, November 22, 2025, 16:00 Hrs [IST] iZafe Group AB (publ.), a li ...
Pharmabiz

Call for expressions of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee

Call for expressions of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee ...
Pharmabiz

Alvotech & Advanz Pharma receive marketing approval across the EEA for Gobivaz, a first-in-market biosimilar to Simponi

Reykjavik, Iceland Saturday, November 22, 2025, 14:00 Hrs [IST] ...
Pharmabiz

Mesoblast and BMT CTN to initiate pivotal trial of Ryoncil as part of first-line regimen in adults with severe acute GvHD refractory to steroids

Mesoblast and BMT CTN to initiate pivotal trial of Ryoncil as part of first-line regimen in adults with severe acute GvHD refractory to steroids: Melbourne, Australia Saturday, No ...
Pharmabiz

GSK subsidiary, Tesaro initiates litigation against AnaptysBio

GSK subsidiary, Tesaro, Inc., confirms it has initiated litigation against AnaptysBio, Inc. in the Delaware Chancery Court. This action contends that recent conduct by AnaptysBio is in material breach ...
Pharmabiz

Medical Ventures strengthens Philippine healthcare with advanced MRI centre in Bulacan

Medical Ventures strengthens Philippine healthcare with advanced MRI centre in Bulacan: Our Bureau, Mumbai Saturday, November 22, 2025, 11:00 Hrs [IST] The Province of Bulacan has ...
Pharmabiz

Abbott enters agreement to acquire Exact Sciences

Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics segments, serving millions ...
Pharmabiz

DGTR issues list of parties regarding bilateral safeguard probe on imports of DOTP, DEHCH from Korea

DGTR issues list of parties regarding bilateral safeguard probe on imports of DOTP, DEHCH from Korea: Shardul Nautiyal, Mumbai Saturday, November 22, 2025, 09:00 Hrs [IST] The Dir ...